Mechanisms influencing bone metabolism in chronic illness

被引:32
作者
Daci, E [1 ]
van Cromphaut, S [1 ]
Bouillon, R [1 ]
机构
[1] Katholieke Univ Leuven, Lab Expt Geneeskunde & Endocrinol, Louvain, Belgium
关键词
D O I
10.1159/000064758
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bone is permanently renewed by the coordinated actions of bone-resorbing osteoclasts and bone-forming osteoblasts, which model and remodel bone structure during growth and adult life. The origin of osteoblastic cells (osteoblasts, osteocytes and bone-lining cells) differs from that of osteoclasts, but both cell groups communicate with each other using cytokines and cell-cell contact as to optimally maintain bone homeostasis. This communication in many ways uses the same players as the communication between cells in the immune system. During acute life-threatening illness massive bone resorption is the rule, while bone formation is suppressed. During chronic illness, the balance between bone formation and bone resorption also shifts, frequently resulting in decreased bone mass and density. Several factors may contribute to the osteopenia that accompanies chronic illness, the most important being undernutrition and low body weight, inflammatory cytokines, disorders of the neuroendocrine axis (growth hor-mone/IGF-1 disturbances, thyroid and gonadal deficiency), immobilization, and the long-term use of glucocorticoids. Their combined effects not only influence the generation and activity of all bone cells involved, but probably also regulate their life span by apoptotic mechanisms. Osteopenia or even osteoporosis and bone fragility, and before puberty also decreased linear growth and lower peak bone mass are therefore frequent consequences of chronic illnesses. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:44 / 51
页数:8
相关论文
共 24 条
[1]  
BARAN D, 2001, OSTEOPOROSIS, V2, P229
[2]   The incidence of fracture among patients with inflammatory dowel disease - A population-based cohort study [J].
Bernstein, CN ;
Blanchard, JF ;
Leslie, W ;
Wajda, A ;
Yu, BN .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (10) :795-799
[3]   The molecular biology of bone resorption due to chronic otitis media [J].
Chole, RA .
IMMUNOLOGIC DISEASES OF THE EAR, 1997, 830 :95-109
[4]   Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass [J].
Ducy, P ;
Amling, M ;
Takeda, S ;
Priemel, M ;
Schilling, AF ;
Beil, FT ;
Shen, JH ;
Vinson, C ;
Rueger, JM ;
Karsenty, G .
CELL, 2000, 100 (02) :197-207
[5]   Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation [J].
Ducy, P ;
Zhang, R ;
Geoffroy, V ;
Ridall, AL ;
Karsenty, G .
CELL, 1997, 89 (05) :747-754
[6]   A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development [J].
Ducy, P ;
Starbuck, M ;
Priemel, M ;
Shen, JH ;
Pinero, G ;
Geoffroy, V ;
Amling, M ;
Karsenty, G .
GENES & DEVELOPMENT, 1999, 13 (08) :1025-1036
[7]   DELAYED SOMATIC GROWTH AND PUBERTAL DEVELOPMENT IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED HEMOPHILIAC BOYS - HEMOPHILIA GROWTH AND DEVELOPMENT STUDY [J].
GERTNER, JM ;
KAUFMAN, FR ;
DONFIELD, SM ;
SLEEPER, LA ;
SHAPIRO, AD ;
HOWARD, C ;
GOMPERTS, ED ;
HILGARTNER, MW .
JOURNAL OF PEDIATRICS, 1994, 124 (06) :896-902
[8]  
Gough A, 1998, J RHEUMATOL, V25, P1282
[9]   Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa [J].
Grinspoon, S ;
Thomas, E ;
Pitts, S ;
Gross, E ;
Mickley, D ;
Miller, K ;
Herzog, D ;
Klibanski, A .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (10) :790-794
[10]   The role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases [J].
Hofbauer, LC ;
Heufelder, AE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2355-2363